• Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Lekhim-Obukhiv LLC
    • UAB «LEKHIM-VILNIUS»
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • Partners
  • Production
    • Medicinal products
    • Veterinary products
    • Mineral water
  • PHARMACIES
  • Export
  • News
  • Contacts
Products
/
Back to catalog
Home / Products / Ciprofloxacin

Ciprofloxacin

250 mg № 10
Группа действия
Antimicrobial agents for systemic use
Действующее вещество
Ciprofloxacin hydrochloride
Лекарственная форма
Film-coated tablets
Код АТС
J01MA02
RX/OTC
RX
Регистрационное удостоверение №
UA/8660/01/01

General properties

Фармакотерапевтическая группа

Antibacterials for systemic use. The group of fluoroquinolones.

Показания

Ciprofloxacin is indicated for treatment of the following infections: before the initiation of the therapy special attention should be paid to all available information as to the resistance to Ciprofloxacin.

Official recommendations as to the independent use of anti-bacterial agents should be considered.

Adults:

– lower respiratory tract infections caused by gram-negative bacteria;

– pneumonia;

– middle ear infections (chronic otitis media with effusion, severe course of otitis of external ear);

– exacerbations of chronic sinusitis, especially if caused by gram-negative bacteria;

– urinary tract infections;

– gonococcus urethritis and cervicitis;

– orchiepididymitis, caused by Neisseria gonorrhoeae in particular;

– inflammatory diseases of pelvic organs, caused by Neisseria gonorrhoeae in particular.

With the above mentioned infections of genital tract if Neisseria gonorrhoeae is known or suspected as a causative agent, it is especially important to obtain local information as to the resistance to Ciprofloxacin and confirm sensitivity by the laboratory analysis.

– gastro-intestinal infections (for example, traveler's diarrhea;

– intra-abdominal infections;

– skin and soft tissues infections caused by gram-negative bacteria;

– bones and joints infections;

– treatment of infections in patients with neutropenic;

– prevention of infections in patients with neutropenic;

– prevention of invasive infections caused by Neisseria meningitidis;

– pulmonary anthrax (post-exposure prophylaxis and curative therapy).

Children and adolescents

– bronchopulmonary infections in cystic fibrosis, caused by Pseudomonas aeruginosa. (in clinical trials children aged 5 to 17 years received the treatment);

– complicated urinary tract infections and pyelonephritis (in clinical trials children aged 5 to 17 years received the treatment);

– pulmonary anthrax (post-exposure prophylaxis and curative therapy).

The treatment should be initiated only by the physician experienced in treatment of cystic fibrosis and/or severe infections in children and adolescents.

Противопоказания

Hypersensitivity to Ciprofloxacin or any other chemotherapeutic agents of quinolone group and other drug components; concomitant use with Tizanidine due to clinically significant adverse effects (arterial hypotension, sleepiness) related to increase of Tizanidine concentration in blood plasma; glucose-6-phosphate dehydrogenase deficiency.

Pharmaceutical characteristics

Основные физико-химические свойства

Round coated tablets of white or white with yellowish tint colour, biconvex. At fracture when viewed under a magnifying glass a core surrounded by one continuous layer is viewed.

Срок годности
3 years.
Условия хранения

Store in the original packaging at temperature not exceeding 25 °C. Keep out of reach of children.

Производитель
PJSC "Technolog".
Местонахождение
8, Stara Prorizna st., Uman 20300 Cherkasy region, Ukraine.
Back to catalog
  • About company
    • Managing company “Lekhim”
    • Manufacturing site “Lekhim-Kharkiv”
    • Manufacturing site “Technolog”
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • News/Events
    • Partners
  • Products
    • Browse by group of action
    • Browse alphabetically
    • Browse by active ingredient
  • Export
    • Foreign economic activity
  • Contact information
Поиск по сайту
Designed in
© 2022. Лекхим.
  • Main
  • About company
    • About company
    • PJSC "Technolog"
    • PJSC “Lekhim-Kharkiv”
    • Lekhim-Obukhiv LLC
    • UAB «LEKHIM-VILNIUS»
    • Safety and pharmacovigilance (Technolog)
    • Safety and pharmacovigilance (Kharkiv)
    • Partners
  • Production
    • Medicinal products
    • Veterinary products
    • Mineral water
  • PHARMACIES
  • Export
  • News
  • Contacts
Поиск по сайту
Поиск по сайту